Morphosys Stock Price, News & Analysis
Company Description
Morphosys (NASDAQ: MOR) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $2.9B, ranking #1,886 among all listed U.S. companies by market cap.
MOR stock has declined 100.0% over the past year. Shares last traded at $18.64.
This page provides a comprehensive overview of MOR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Morphosys (MOR) stock last traded at $18.64. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $2.9B, MOR is classified as a mid-cap stock with approximately 150.7M shares outstanding.
Latest News
Morphosys has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, conferences, clinical trial. View all MOR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MOR Company Profile & Sector Positioning
Morphosys (MOR) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.